Golestan University of Medical Sciences Repository

Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study

Sheikh, M. and Shakeri, R. and Poustchi, H. and Pourshams, A. and Etemadi, A. and Islami, F. and Khoshnia, M. and Gharavi, A. and Roshandel, G. and Khademi, H. and Sepanlou, S.G. and Hashemian, M. and Fazel, A. and Zahedi, M. and Abedi-Ardekani, B. and Boffetta, P. and Dawsey, S.M. and Pharoah, P.D. and Sotoudeh, M. and Freedman, N.D. and Abnet, C.C. and Day, N.E. and Brennan, P. and Kamangar, F. and Malekzadeh, R. (2020) Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study. The Lancet Global Health, 8 (5). e649-e660.

Full text not available from this repository.


Background: Evidence is emerging for a role of opiates in various cancers. In this study, we aimed to investigate the association between regular opium use and cancer incidence. Methods: This study was done in a population-based cohort of 50 045 individuals aged 40�75 years from northeast Iran. Data on participant demographics, diet, lifestyle, opium use, and different exposures were collected upon enrolment using validated questionnaires. We used proportional hazards regression models to estimate hazard ratios (HRs) and corresponding 95 CIs for the association between opium use and different cancer types. Findings: During a median 10 years of follow-up, 1833 participants were diagnosed with cancer. Use of opium was associated with an increased risk of developing all cancers combined (HR 1·40, 95 CI 1·24�1·58), gastrointestinal cancers (1·31, 1·11�1·55), and respiratory cancers (2·28, 1·58�3·30) in a dose-dependent manner (ptrend<0·001). For site-specific cancers, use of opium was associated with an increased risk of developing oesophageal (1·38, 1·06�1·80), gastric (1·36, 1·03�1·79), lung (2·21, 1·44�3·39), bladder (2·86, 1·47�5·55), and laryngeal (2·53, 1·21�5·29) cancers in a dose-dependent manner (ptrend<0·05). Only high-dose opium use was associated with pancreatic cancer (2·66, 1·23�5·74). Ingestion of opium (but not smoking opium) was associated with brain (2·15, 1·00�4·63) and liver (2·46, 1·23�4·95) cancers in a dose-dependent manner (prend<0·01). We observed consistent associations among ever and never tobacco users, men and women, and individuals with lower and higher socioeconomic status. Interpretation: Opium users have a significantly higher risk of developing cancers in different organs of the respiratory, digestive, and urinary systems and the CNS. The results of this analysis show that regular use of opiates might increase the risk of a range of cancer types. Funding: World Cancer Research Fund International, Cancer Research UK, Tehran University of Medical Sciences, US National Cancer Institute, International Agency for Research on Cancer. © 2020 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY-NC-ND 3.0 IGO license which permits users to download and share the article for non-commercial purposes, so long as the article is reproduced in the whole without changes, and provided the original source is properly cited. This article shall not be used or reproduced in association with the promotion of commercial products, services or any entity. There should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL

Item Type: Article
Additional Information: cited By 1
Subjects: فارماکولوژی QV
> دانشکده داروسازی > فارماکولوژی QV

آسیب شناسی QZ
مقالات نمایه شده محققین دانشگاه در سایت ,Web of Science ,Scopus
Divisions: معاونت تحقیقات و فناوری
Depositing User: GOUMS
Date Deposited: 16 May 2020 08:14
Last Modified: 16 May 2020 08:14
URI: http://eprints.goums.ac.ir/id/eprint/10629

Actions (login required)

View Item View Item